Zobrazeno 1 - 10
of 314
pro vyhledávání: '"Jean-Michel Hannoun-Levi"'
Autor:
Marta Gimeno-Morales, Laura Motisi, Natalia Rodriguez-Spiteri, Fernando Martínez-Regueira, Tucker Worthington, Vratislav Strnad, Jean Michel Hannoun-Levi, Cristina Gutierrez
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 1, Pp 72-83 (2024)
Externí odkaz:
https://doaj.org/article/903c2edc295c4818ac11ed3210f5fcca
Autor:
Jonathan Benzaquen, Pierre-Yves Bondiau, Josiane Otto, Charles-Hugo Marquette, Jean-Philippe Berthet, Arash O. Naghavi, Renaud Schiappa, Jean-Michel Hannoun-Levi, Bernard Padovani, Jérôme Doyen
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Early-stage lung cancer, primarily treated with surgery, often occur in poor surgical candidates (impaired respiratory function, prior thoracic surgery, severe comorbidities). Stereotactic ablative radiotherapy (SABR) is a non-inv
Externí odkaz:
https://doaj.org/article/a6a8db3e61234746aa921ee21d0ed612
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 38, Iss , Pp 71-76 (2023)
Purpose: To analyze long-term oncological outcome after 2nd conservative treatment (2ndCT) for patients with ipsilateral 2nd ipsilateral breast tumor event (2ndIBTE). Materials/methods: In this retrospective observational study (N°F20210402152843),
Externí odkaz:
https://doaj.org/article/7317cc3d03374c8c882c1f2b974e3c5c
Autor:
Manon Kissel, Luc Ollivier, Ingrid Fumagalli, Pascal Pommier, Cyrus Chargari, Pierre Blanchard, Didier Peiffert, Jean-Michel Hannoun-Levi
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 14, Iss 6, Pp 501-511 (2022)
Externí odkaz:
https://doaj.org/article/f967dd80f186400d9f4e7cefad62b372
Autor:
Jean-Michel Hannoun-Levi, Marie-Eve Chand-Fouche, Tanguy Pace-Loscos, Mathieu Gautier, Jocelyn Gal, Renaud Schiappa, Nina Pujol
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 64-70 (2022)
Purpose: To report the results of the Single Fraction Early Prostate Irradiation (SiFEPI) phase 2 prospective trial. Materials/Methods: The SiFEPI trial (NCT02104362) evaluated a single fraction of high-dose rate brachytherapy (HDB) for low- (LR) and
Externí odkaz:
https://doaj.org/article/ba481b83c50843eb84967432af6eff73
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 35, Iss , Pp 1-8 (2022)
Purpose: To analyze the literature that addresses radiation therapy for intermediate and high-risk prostate cancer (PC) in the elderly. Patients and methods: A PubMed literature search was conducted including articles from 01/01/2000 to 30/06/21, wit
Externí odkaz:
https://doaj.org/article/c89ae346531f40539b34de1a2b2c7893
Autor:
Delphine Marotte, Jocelyn Gal, Renaud Schiappa, Mathieu Gautier, Rabia Boulahssass, Marie-Eve Chand-Fouche, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 35, Iss , Pp 104-109 (2022)
Purpose: To analyze the oncological outcome in elderly (>70 years) prostate cancer after high-dose rate brachytherapy (HDB) boost. Materials/methods: In this retrospective study, patients with intermediate (IR) and high-risk (HR) prostate cancer unde
Externí odkaz:
https://doaj.org/article/8071efa1a0ca4367b726ca8c89a6a5c1
Autor:
Jean-Pierre Gerard, Lucile Montagne, Brice Thamphya, Jerôme Doyen, Renaud Schiappa, Karene Benezery, Sophie Gourgou, Catherine Dejean, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 33, Iss , Pp 70-76 (2022)
Introduction: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a “watch and wait” strategy (W&W) is a field of research. Planned
Externí odkaz:
https://doaj.org/article/43b88a4daf3b4ce29fc68a738635b243
Autor:
Maud le Guyader, Daniel Lam Cham Kee, Brice Thamphya, Renaud Schiappa, Mathieu Gautier, Marie-Eve Chand-Fouche, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 32, Iss , Pp 15-23 (2022)
Purpose: Brachytherapy (BT) boost after radio-chemotherapy (RCT) is a standard of care in the management of locally advanced cervical cancer (LACC). As there is no consensus on high-dose-rate (HDR) BT fractionation schemes, our aim was to report the
Externí odkaz:
https://doaj.org/article/29529ff497fa41c3bd5287d8155c5c6b
Autor:
Nicolas Martz, Nicolas Benziane-Ouaritini, Mathieu Gautier, Isabelle Brenot-Rossi, Lucile Montagne, Naji Salem, Yohan Bodokh, Jean-Michel Hannoun-Levi
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 5, Pp 593-597 (2021)
The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis. We present th
Externí odkaz:
https://doaj.org/article/0fd9b85489504033a35246592828363a